William Sandborn, MD, discusses results from the phase 2 clinical trial showing that the drug Tofacitinib achieved clinical response and remission in certain patients suffering from ulcerative colitis.
17 Notes/ Hide
-
elderhelp reblogged this from ucsdhealthsciences and added:
Interesting.
-
blue-lights-and-tea reblogged this from ucsdhealthsciences
-
master-net likes this
-
adian27 reblogged this from ucsdhealthsciences
-
adian27 likes this
-
hypothesise likes this
-
more-like-coolitis reblogged this from ucsdhealthsciences
-
medregenliou likes this
-
naturalnightnurse likes this
-
naturalnightnurse reblogged this from ucsdhealthsciences
-
catty1 likes this
-
endless-emotion likes this
-
thecoloradopursuit likes this
-
clivers reblogged this from ucsdhealthsciences and added:
Tofacitnib = also for Rheumatoid Arthritis. I can’t wait for this pill to come out! I’m not trying to put all my eggs in...
-
flebilis likes this
-
ucsdspecialcollections likes this
-
ucsdhealthsciences posted this
